Insider Trading History of Attar Eyal C.

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of Attar Eyal C. since 2019. This trader's CIK number is 1789076. At the time of last reporting, Attar Eyal C. was the CHIEF MEDICAL OFFICER of Vor Biopharma Inc.. (stock ticker symbol VOR). Also see all insider trading activities at Vor Biopharma Inc..

Note that in the past Attar Eyal C. also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Vor Biopharma Inc. (VOR) by Attar Eyal C.

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2025 VOR 0 $0 2,554 $3,498 0 $0
2024 VOR 0 $0 24,979 $33,273 0 $0

Yearly summary of insider trading at Aprea Therapeutics, Inc. (APRE) by Attar Eyal C.

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2022 APRE 0 $0 36,000 $62,280 0 $0
2021 APRE 0 $0 15,968 $74,730 0 $0
2019 APRE 400 $6,000 0 $0 0 $0


Insider trading activities at 2 companies by Attar Eyal C.:

1. Vor Biopharma Inc. (VOR)

2. Aprea Therapeutics, Inc. (APRE)

Table 1. Insider trading of Vor Biopharma Inc. (VOR) by Attar Eyal C.

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2025-02-10 VOR Sale 2,554 1.37 3,498
2024-12-27 VOR Sale 10,334 1.25 12,917
2024-06-03 VOR Sale 14,645 1.39 20,356

Table 2. Insider trading of Aprea Therapeutics, Inc. (APRE) by Attar Eyal C.

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2022-02-28 APRE Sale 36,000 1.73 62,280
2021-09-16 APRE Sale 15,968 4.68 74,730
2019-10-07 APRE Buy 400 15.00 6,000

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Attar Eyal C. (CHIEF MEDICAL OFFICER of Vor Biopharma Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.